Structural changes in lower ionosphere wind trends at midlatitudes

Long-term variability of the mesosphere/lower thermosphere (lower E region ionosphere) since 1970 has been analyzed using wind data series obtained at Collm (52° N, 15° E) using the LF drift method and at Obninsk (55° N, 37° E) applying VHF meteor radar. Applying piecewise linear trend analysis with a priori unknown number and positions of breakpoints shows that trend models with breakpoints are generally to be preferred against straight lines. There is a strong indication for a change of trends in wind parameters around 1975–1980. Similar changes are also found in the lower atmosphere, e.g., in tropospheric temperatures. This indicates a coupling between atmospheric layers at time scales of decades

Трубка ендотрахеальна з системою для екстратубажного введення речовини

Трубка ендотрахеальна з системою для екстратубажного введення речовин, що включає інтубаційну трубку із конектором та герметизуючою манжетою, яка відрізняється тим, що лікарські засоби вводяться через канал в порожнину герметизуючої манжети, у стінках якої виконані перфоративні зрошуючі отвори діаметром 0,3 мм

DESIGN OF PUBLICITY ACTIVITY FOR SPECIAL PURPOSE AIRLINE / SPECIALIOSIOS PASKIRTIES AVIAKOMPANIJOS REKLAMINĖS KAMPANIJOS MODELIAVIMAS

The features of publicity activity for special purpose airline are considered in the article. The possible ways of planning of publicity activity for special purpose airline are offered at implementation of agro aviation works. Theoretical bases of advancement of agro aviation works in the agrarian market of Ukraine are presented. The model of planning of advertising is developed in relation to its periodicity. Santrauka Straipsnyje nagrinėjami specialiosios paskirties aviakompanijos reklaminės kampanijos ypatumai. Pateiktos specialiosios paskirties aviakompanijos reklaminės kampanijos planavimo galimybės atliekant agroaviacinius darbus. Pateiktos agroaviacinių darbų pasiūlos Ukrainos agrarinei rinkai teorinės gairės. Sukurtas reklamos planavimo modelis vertinant jos periodiškumą. Reikšminiai žodžiai: specialios paskirties aviakompanija; reklaminė kampanija; reklama; reklamos planavimas; efektyvumas

Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC-EORP EUROASPIRE V survey in 27 countries

WOS: 000468732700018PubMed ID: 31054483Background and aims: One of the objectives of the ESC-EORP EUROASPIRE V survey is to determine how well European guidelines on the management of dyslipidaemias are implemented in coronary patients. Methods: Standardized methods were used by trained technicians to collect information on 7824 patients from 130 centers in 27 countries, from the medical records and at a visit at least 6 months after hospitalization for a coronary event. All lipid measurements were performed in one central laboratory. Patients were divided into three groups: on high-intensity LDL-C-lowering-drug therapy (LLT), on low or moderate-intensity LLT and on no LLT. Results: At the time of the visit, almost half of the patients were on a high-intensity LLT. Between hospital discharge and the visit, LLT had been reduced in intensity or interrupted in 20.8% of the patients and had been started or increased in intensity in 11.7%. In those who had interrupted LLT or had reduced the intensity, intolerance to LLT and the advice of their physician were reported as the reason why in 15.8 and 36.8% of the cases, respectively. LDL-C control was better in those on a high-intensity LLT compared to those on low or moderate intensity LLT. LDL-C control was better in men than women and in patients with self-reported diabetes. Conclusions: The results of the EUROASPIRE V survey show that most coronary patients have a less than optimal management of LDL-C. More professional strategies are needed, aiming at lifestyle changes and LLT adapted to the need of the individual patient.ESC - EORP; AmgenAmgen; Eli LillyEli Lilly; PfizerPfizer; SanofiSanofi-Aventis; Ferrer; Novo NordiskNovo NordiskThe EUROASPIRE V survey was carried out under the auspices of the ESC - EORP. Since the start of EORP, the following companies have supported the programme: Amgen, Eli Lilly, Pfizer, Sanofi, Ferrer and Novo Nordisk. The sponsors of the EUROASPIRE surveys had no role in the design, data collection, data analysis, data interpretation, decision to publish, or writing the manuscript